HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humans.

Abstract
CpG-containing immunostimulatory DNA sequences (ISS), which signal through TLR9, are being developed as a therapy for allergic indications and have proven to be safe and well tolerated in humans when administrated via the pulmonary route. In contrast, ISS inhalation has unexplained toxicity in rodents, which express TLR9 in monocyte/macrophage lineage cells as well as in plasmacytoid DCs (pDCs) and B cells, the principal TLR9-expressing cells in humans. We therefore investigated the mechanisms underlying this rodent-specific toxicity and its implications for humans. Mice responded to intranasally administered 1018 ISS, a representative B class ISS, with strictly TLR9-dependent toxicity, including lung inflammation and weight loss, that was fully reversible and pDC and B cell independent. Knockout mouse experiments demonstrated that ISS-induced toxicity was critically dependent on TNF-alpha, with IFN-alpha required for TNF-alpha induction. In contrast, human PBMCs, human alveolar macrophages, and airway-derived cells from Ascaris suum-allergic cynomolgus monkeys did not produce appreciable TNF-alpha in vitro in response to ISS stimulation. Moreover, sputum of allergic humans exposed to inhaled ISS demonstrated induction of IFN-inducible genes but minimal TNF-alpha induction. These data demonstrate that ISS induce rodent-specific TNF-alpha-dependent toxicity that is absent in humans and reflective of differential TLR9 expression patterns in rodents versus humans.
AuthorsJohn D Campbell, Yan Cho, Martyn L Foster, Holger Kanzler, Melissa A Kachura, Jeremy A Lum, Marianne J Ratcliffe, Atul Sathe, Andrew J Leishman, Ash Bahl, Mark McHale, Robert L Coffman, Edith M Hessel
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 119 Issue 9 Pg. 2564-76 (Sep 2009) ISSN: 1558-8238 [Electronic] United States
PMID19726873 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Cytokines
  • Oligodeoxyribonucleotides
  • TLR9 protein, human
  • Tlr9 protein, mouse
  • Toll-Like Receptor 9
  • Tumor Necrosis Factor-alpha
  • 1018 oligonucleotide
Topics
  • Adjuvants, Immunologic (toxicity)
  • Administration, Inhalation
  • Animals
  • Asthma (genetics, immunology)
  • Bronchoalveolar Lavage Fluid (immunology)
  • Cytokines (metabolism)
  • Dendritic Cells (drug effects, immunology)
  • Humans
  • In Vitro Techniques
  • Lung (drug effects, immunology, pathology)
  • Macaca fascicularis
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Oligodeoxyribonucleotides (administration & dosage, genetics, immunology, toxicity)
  • Species Specificity
  • Toll-Like Receptor 9 (agonists, deficiency, genetics, metabolism)
  • Tumor Necrosis Factor-alpha (deficiency, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: